Evidence map›Paper›PMID 39840381›Full record

ArticleHemaSphere2025

Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA.

Amira Marouf, Sammara Chaubard, Raphaël Liévin, Jean-Marie Michot, Nicolas Molinari, Julien Rossignol, Doriane Cavalieri, Camille Golfier, Olivier Allangba, Laure Philippe and 33 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Amira MaroufLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications INSERM UMR_S 1163, IMAGINE Institute, Université Paris Cité 24, boulevard du Montparnasse PARIS Île-de-France France.ORCID https://orcid.org/0000-0002-5707-7290
Sammara ChaubardDepartment of Hematology Limoges University Hospital Limoges France.
Raphaël LiévinLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications INSERM UMR_S 1163, IMAGINE Institute, Université Paris Cité 24, boulevard du Montparnasse PARIS Île-de-France France.
Jean-Marie MichotDepartment of Drug Development, Gustave Roussy Institute Paris-Saclay University Villejuif France.
Nicolas MolinariInstitut Desbrest d'Épidémiologie et de Santé Publique CHU Montpellier France.
Julien RossignolDepartment of Hematology, Necker Children's Hospital Assistance Publique-Hôpitaux de Paris (APHP) Paris France.
Doriane CavalieriDepartment of Hematology CHU Lille Lille France.
Camille GolfierDepartment of Hematology Lyon Civils Hospices Lyon France.
Olivier AllangbaHematology, CH Saint Brieuc Saint Brieuc France.
Laure PhilippeDepartment of Hematology Annecy Genevois Hospital Epagny Metz-Tessy France.
Benoît TessoulinDepartment of Hematology Nantes University Hospital Nantes France.
Adrien ChauchetDepartment of Hematology CHU Besançon Besançon France.
Bénédicte DeauDepartment of Hematology Cochin's Hospital, Assistance Publique-Hôpitaux de Paris (APHP) Paris France.
Lucie ObericDepartment of Hematology Cancer University Institute of Toulouse Oncopole Toulouse France.
Jacques VargaftigDepartment of Hematology Institut Curie Saint Cloud France.
Aline MoignetDepartment of Hematology CHU Rennes, Rennes University, Inserm U1236 Rennes France.
Aline ClavertDepartment of Hematology CHU Angers Angers France.
Rémy DuleryDepartment of Hematology and Cell therapy Hôpital Saint Antoine Paris France.
Gabriel BrisouDepartment of Hematology Institut Paoli Calmettes Marseille France.
Stéphanie TardyDepartment of Hematology Annecy Genevois Hospital Epagny Metz-Tessy France.
Virginie FataccioliDepartment of Pathology, Henri Mondor University Hospital Assistance Publique-Hôpitaux de Paris (APHP) Créteil France.
Roch HouotDepartment of Hematology CHU Rennes, Rennes University, Inserm U1236 Rennes France.
René O CasasnovasDepartment of Hematology CHU Dijon Dijon France.
Catherine ThieblemontDepartment of Hematology Université De Paris & APHP, Hemato-Oncologie, Hôpital Saint Louis Paris France.
Hervé GhesquièresDepartment of Hematology Lyon Civils Hospices Lyon France.
Sylvain CarrasDepartment of Hematology CHU Grenoble Alpes La Tronche France.
Steven Le GouillDepartment of Hematology Institut Curie Saint Cloud France.
Guillaume CartronDepartment of Hematology CHU Montpellier Montpellier France.
Vincent RibragDepartment of Drug Development, Gustave Roussy Institute Paris-Saclay University Villejuif France.
Morgane CheminantDepartment of Hematology, Necker Children's Hospital Assistance Publique-Hôpitaux de Paris (APHP) Paris France.
Ambroise MarçaisDepartment of Hematology, Necker Children's Hospital Assistance Publique-Hôpitaux de Paris (APHP) Paris France.
Felipe SuarezDepartment of Hematology, Necker Children's Hospital Assistance Publique-Hôpitaux de Paris (APHP) Paris France.
Aurélien MarabelleDepartment of Oncology Institut Gustave Roussy Villejuif France.
Olivier TournilhacDepartment of Hematology CHU Clermont-Ferrand Clermont-Ferrand France.
Gandhi DamajDepartment of Hematology CHU Côte de Nacre Caen Normandie Caen France.
Philippe GaulardDepartment of Pathology, Henri Mondor University Hospital Assistance Publique-Hôpitaux de Paris (APHP) Créteil France.
Laurence De LevalDepartment of Laboratory Medicine and Pathology Institute of Pathology Lausanne Switzerland.
François LemonnierDepartment of Hematology Henri Mondor University Hospital, Assistance Publique -Hôpitaux de Paris (APHP) Créteil France.
Emmanuel BachyDepartment of Hematology Lyon Civils Hospices Lyon France.
Sylvie ChevretBiostatistics and Clinical Epidemiology Unit, Saint-Louis Hospital AP-HP France.
Olivier HermineLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications INSERM UMR_S 1163, IMAGINE Institute, Université Paris Cité 24, boulevard du Montparnasse PARIS Île-de-France France.
Lucile CouronnéLaboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications INSERM UMR_S 1163, IMAGINE Institute, Université Paris Cité 24, boulevard du Montparnasse PARIS Île-de-France France.
Arnaud JaccardDepartment of Hematology Limoges University Hospital Limoges France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39840381
PMCPMC11746926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.